NeuroBo Pharmaceuticals Investor Presentation Deck
December 2023, 25 slides
  1. NeuroBo Pharmaceuticals
  2. Related Decks
  3. Investor Presentation Decks
pharmaceuticals as | NeuroBo Pharmaceuticals
forward looking statements | NeuroBo Pharmaceuticals
strong leadership team | NeuroBo Pharmaceuticals
compelling investment opportunity a | NeuroBo Pharmaceuticals
pipeline a mash obesity | NeuroBo Pharmaceuticals
tay elm cee tea ale targeting to increase shareholder value a lut | NeuroBo Pharmaceuticals
as orally available potential first in class agonist | NeuroBo Pharmaceuticals
competitive differentiation | NeuroBo Pharmaceuticals
effect on pathogenesis in mash as a | NeuroBo Pharmaceuticals
in glucose control when administered with other therapies gra | NeuroBo Pharmaceuticals
differentiated anti inflammatory effect in mash mice | NeuroBo Pharmaceuticals
synergistic effects with a inhibitor in mice | NeuroBo Pharmaceuticals
ongoing phase a in mash | NeuroBo Pharmaceuticals
potential advantages in mash | NeuroBo Pharmaceuticals
as a novel dual agonist for the treatment of obesity | NeuroBo Pharmaceuticals
competitive differentiation | NeuroBo Pharmaceuticals
mechanism of action | NeuroBo Pharmaceuticals
therapeutic potential in obesity comparison | NeuroBo Pharmaceuticals
therapeutic potential in obesity comparison | NeuroBo Pharmaceuticals
phase study to evaluate and safety | NeuroBo Pharmaceuticals
and capitalization as | NeuroBo Pharmaceuticals
and capitalization table | NeuroBo Pharmaceuticals
investment thesis as | NeuroBo Pharmaceuticals
compelling investment opportunity | NeuroBo Pharmaceuticals
thank you as | NeuroBo Pharmaceuticals
See More
NeuroBo Pharmaceuticals
Investor Presentation Decks
Biotechnology Decks
Healthcare Decks
Explore Topics
Pharmaceutical
Inflammation
Food
Liver
Plasma
Clinical trial
Recent decks by NeuroBo Pharmaceuticals
Investor Presentation
January 2024
Securities Offering
October 2022
Investor Presentation
March 2021
See all presentations by NeuroBo Pharmaceuticals (4 decks)
Related decks
Axcella Health
Results
September 2022
Hepion Pharmaceuticals
Results
October 2022
Arbutus Biopharma
Results
November 2022
Aeglea BioTherapeutics
Investor Day
October 2022
Arbutus Biopharma
Investor Presentation
March 2023
Arbutus Biopharma
Investor Presentation
August 2023
Albireo Pharma
Results
October 2022
Aeglea BioTherapeutics
Investor Presentation
March 2023
Recent decks by NeuroBo Pharmaceuticals
See all presentations (4 decks)
Investor Presentation
January 2024
Securities Offering
October 2022
Investor Presentation
March 2021
Axcella Health
Results
September 2022
Hepion Pharmaceuticals
Results
October 2022
Arbutus Biopharma
Results
November 2022
Aeglea BioTherapeutics
Investor Day
October 2022
Arbutus Biopharma
Investor Presentation
March 2023
Arbutus Biopharma
Investor Presentation
August 2023
Albireo Pharma
Results
October 2022
Aeglea BioTherapeutics
Investor Presentation
March 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights